Department of Radiology, U.C. Davis, Sacramento, CA, USA.
EXPLORER Molecular Imaging Center, UC Davis Health, 3195 Folsom Blvd., Suite 120, Sacramento, CA 95816, USA.
PET Clin. 2021 Jan;16(1):1-7. doi: 10.1016/j.cpet.2020.09.006.
This work outlines the clinical implementation of total-body PET/CT from the time of installation at UC Davis EXPLORER Molecular Imaging Center in May 2019 to date (September 2020). This process has not been without challenges: logistical, technical, and medical problems were all encountered and are discussed. The mutual learning/teaching engagement among nuclear medicine technologists, research staff, radiologists, and referring physicians has been the key to the past year's achievements; these include development of ground-breaking clinical protocols for a range of Food and Drug Administration-approved radiotracers, and the attainment of a measure of expertise in clinical total-body PET/CT.
本工作概述了 2019 年 5 月在加州大学戴维斯分校 EXPLORER 分子影像中心安装后至今（2020 年 9 月）全身 PET/CT 的临床实施情况。这一过程并非没有挑战：遇到了后勤、技术和医疗方面的问题，并进行了讨论。核医学技术人员、研究人员、放射科医生和转诊医生之间的相互学习/教学活动是过去一年取得成就的关键；其中包括为一系列获得美国食品和药物管理局批准的放射性示踪剂制定开创性的临床方案，并在全身临床 PET/CT 方面获得一定的专业知识。
